Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy.
about
Challenges and opportunities for the implementation of virological testing in resource-limited settingsEffect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
P2860
Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@ast
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@en
type
label
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@ast
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@en
prefLabel
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@ast
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@en
P2860
P50
P921
P356
P1476
Virological breakthrough: a ri ...... ort on antiretroviral therapy.
@en
P2860
P304
P356
10.1155/2011/469127
P577
2011-05-08T00:00:00Z